Asset Details
Do you wish to reserve the book?
Beyond starving cancer: anti-angiogenic therapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Beyond starving cancer: anti-angiogenic therapy
Do you wish to request the book?
Beyond starving cancer: anti-angiogenic therapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Beyond starving cancer: anti-angiogenic therapy
2024
Overview
Tumor blood vessels contribute to cancer progression by supplying nutrients and oxygen to the tumor, removing waste products, and providing a pathway to distant organs. Current angiogenesis inhibitors primarily target molecules in the vascular endothelial growth factor (VEGF) signaling pathway, inhibiting cancer growth and metastasis by preventing the formation of blood vessels that feed cancer. They also normalize vascular structural abnormalities caused by excess VEGF and improve reflux, resulting in increased drug delivery to cancer tissue and immune cell mobilization. As a result, by normalizing blood vessels, angiogenesis inhibitors have been shown to enhance the effects of chemotherapy and immunotherapy. We present findings on the characteristics of tumor vascular endothelial cells that angiogenesis inhibitors target.
Publisher
Springer Nature Singapore,Springer,Springer Nature B.V
Subject
/ Angiogenesis Inhibitors - therapeutic use
/ Animals
/ Cancer
/ Drugs
/ Humans
/ Hypoxia
/ Imaging
/ Kinases
/ Medicine
/ Mutation
/ Neovascularization, Pathologic - drug therapy
/ Special Feature: Review Article
/ Tumors
/ Vascular endothelial growth factor
/ Vascular Endothelial Growth Factor A - antagonists & inhibitors
/ Vascular Endothelial Growth Factor A - metabolism
/ Vehicles
